Adrenergic and cholinergic stimulation of 32P-labeling of phospholipids in rabbit iris muscle.
D000322:Adrenergic Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology; D000818:Animals; D004075:Diglycerides / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000494:pharmacology; D066298:In Vitro Techniques; D007498:Iris / Q000378:metabolism*; D008297:Male; D009132:Muscles / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D010712:Phosphatidic Acids / Q000378:metabolism; D010713:Phosphatidylcholines / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism*; D010761:Phosphorus Radioisotopes; D010770:Phosphotransferases / Q000378:metabolism; D011817:Rabbits; D011941:Receptors, Adrenergic / Q000187:drug effects; D011950:Receptors, Cholinergic / Q000187:drug effects; D013570:Synaptic Membranes / Q000187:drug effects; D013696:Temperature
D000322:Adrenergic Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000588:Amines; D004075:Diglycerides; D010277:Parasympathomimetics; D010712:Phosphatidic Acids; D010713:Phosphatidylcholines; D010716:Phosphatidylinositols; D010743:Phospholipids; D010761:Phosphorus Radioisotopes; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D010770:Phosphotransferases; D005947:Glucose; D009638:Norepinephrine